£92.50

Springer Breast Cancer Chemosensitivity: 608 (Advances in Experimental Medicine and Biology, 608)

Price data last checked 11 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 1 month ago.

£93 today · all-time low £91 (Aug 2026) · usually £91

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 80 days · 80 data points (no recent data)

Historical
Generating forecast…
£93.74 £90.24 £91.01 £91.77 £92.53 £93.29 £94.06 27 June 2026 16 July 2026 05 August 2026 25 August 2026 14 September 2026

Price Distribution

Price distribution over 80 days • 4 price levels

Days at Price
Current Price
48 days 15 days 1 day · current 16 days 0 12 24 36 48 £91 £92 £93 £94 Days at Price

Price Analysis

Most common price: £91 (48 days, 60.0%)

Price range: £91 - £94

Price levels: 4 different prices over 80 days

Description

In Breast Cancer Chemosensitivity, a group of world leading experts review critical aspects of resistance to systemic therapy in breast cancer patients. Beginning with a clinical overview of the problem Breast Cancer Chemosensitivity moves on to focus on the latest findings of molecular mechanisms of drug resistance. These include in-depth discussions on multidrug resistance by P-glycoprotein and the multidrug resistance protein family, resistance to therapeutic agent-induced apoptosis, cell cycle deregulation, deregulation of DNA repair, loss of tumor suppressor genes, integrin-mediated adhesion, insulin-like growth factors, epidermal growth factor, and ErbB2 in modulating breast cancer response to systemic therapy, especially, certain chemotherapeutic agents. Breast Cancer Chemosensitivity provides an example of using novel approaches for chemosensitization of breast cancer cells that gives readers an idea about the future direction in breast cancer treatment.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
14 September 2007
Listed Since
01 August 2007

Barcode

No barcode data available

Similar Products You Might Like

Epigenetic Mechanisms in Breast Cancer Therapy and Resistance (Advances in Experimental Medicine and Biology, 1465)
84% match

Epigenetic Mechanisms in Breast Cancer Therapy and Resistance (Advances in Experimental Medicine and Biology, 1465)

Springer

£127.59 01 Aug 2026
Prognostic variables in node-negative and node-positive breast cancer
84% match

Prognostic variables in node-negative and node-positive breast cancer

Springer

£153.04 05 Aug 2026
Improving Outcomes for Breast Cancer Survivors: Perspectives on Research Challenges and Opportunities: 862 (Advances in Experimental Medicine and Biology, 862)
84% match

Improving Outcomes for Breast Cancer Survivors: Perspectives on Research Challenges and Opportunities: 862 (Advances in Experimental Medicine and Biology, 862)

Springer

£78.95 06 Aug 2026
A Practical Guide to Breast Cancer Treatment
83% match

A Practical Guide to Breast Cancer Treatment

Springer

£115.72 04 Aug 2026
A Guide to Breast Cancer Research: From Cellular Heterogeneity and Molecular Mechanisms to Therapy (Advances in Experimental Medicine and Biology, 1464)
83% match

A Guide to Breast Cancer Research: From Cellular Heterogeneity and Molecular Mechanisms to Therapy (Advances in Experimental Medicine and Biology, 1464)

Springer

£112.71 30 Aug 2026
Hormone Receptors in Breast Cancer: 147 (Cancer Treatment and Research, 147)
83% match

Hormone Receptors in Breast Cancer: 147 (Cancer Treatment and Research, 147)

Springer

£80.67 04 Aug 2026
Breast Cancer: Evolving Challenges and Next Frontiers
83% match

Breast Cancer: Evolving Challenges and Next Frontiers

IntechOpen

£119.00 29 Aug 2026
Molecular and Cellular Biology of Multidrug Resistance in Tumour Cells
83% match

Molecular and Cellular Biology of Multidrug Resistance in Tumour Cells

Springer

£67.00 18 Aug 2026
Omics Approaches in Breast Cancer: Towards Next-Generation Diagnosis, Prognosis and Therapy
83% match

Omics Approaches in Breast Cancer: Towards Next-Generation Diagnosis, Prognosis and Therapy

Springer

£74.21 08 Aug 2026
Resistance to Targeted Therapies in Breast Cancer: 16 (Resistance to Targeted Anti-Cancer Therapeutics, 16)
83% match

Resistance to Targeted Therapies in Breast Cancer: 16 (Resistance to Targeted Anti-Cancer Therapeutics, 16)

Springer

£80.65 06 Aug 2026
Signaling Pathways in Breast Cancer: Molecular Mechanisms, Therapeutic Strategies, and Multidrug Resistance
83% match

Signaling Pathways in Breast Cancer: Molecular Mechanisms, Therapeutic Strategies, and Multidrug Resistance

Elsevier

£145.99 04 Aug 2026
Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)
83% match

Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)

Springer

£103.27 08 Aug 2026
Environment and Breast Cancer
83% match

Environment and Breast Cancer

Springer

£108.01 14 Aug 2026
Adjuvant Therapy of Breast Cancer: 60 (Cancer Treatment and Research, 60)
83% match

Adjuvant Therapy of Breast Cancer: 60 (Cancer Treatment and Research, 60)

Springer

£148.28 05 Aug 2026
Changing Paradigms in the Management of Breast Cancer
82% match

Changing Paradigms in the Management of Breast Cancer

Springer

£80.67 14 Sep 2026
Endocrine Therapy of Breast Cancer VI (ESO Monographs)
82% match

Endocrine Therapy of Breast Cancer VI (ESO Monographs)

Springer

£76.42 07 Aug 2026
Resistance to Immunotoxins in Cancer Therapy: 6 (Resistance to Targeted Anti-Cancer Therapeutics, 6)
82% match

Resistance to Immunotoxins in Cancer Therapy: 6 (Resistance to Targeted Anti-Cancer Therapeutics, 6)

Springer

£76.42 06 Aug 2026
Breast Cancer Management for Surgeons: A European Multidisciplinary Textbook
82% match

Breast Cancer Management for Surgeons: A European Multidisciplinary Textbook

Springer

£156.70 05 Aug 2026
Breast Cancer: Origins, Detection, and Treatment: Proceedings of the International Breast Cancer Research Conference London, United Kingdom ― March 24–28, 1985: 43 (Developments in Oncology, 43)
82% match

Breast Cancer: Origins, Detection, and Treatment: Proceedings of the International Breast Cancer Research Conference London, United Kingdom ― March 24–28, 1985: 43 (Developments in Oncology, 43)

Springer

£78.17 05 Aug 2026
Integrative Medicine for Breast Cancer: An Evidence-Based Assessment
82% match

Integrative Medicine for Breast Cancer: An Evidence-Based Assessment

Springer

£65.61 05 Aug 2026
Breast Cancer: Progress in Biology, Clinical Management and Prevention: Proceedings of the International Association for Breast Cancer Research ... March 1989: 58 (Developments in Oncology, 58)
82% match

Breast Cancer: Progress in Biology, Clinical Management and Prevention: Proceedings of the International Association for Breast Cancer Research ... March 1989: 58 (Developments in Oncology, 58)

Springer

£121.35 08 Aug 2026
Breast Cancer: Progress in Biology, Clinical Management and Prevention: Proceedings of the International Association for Breast Cancer Research ... March 1989: 58 (Developments in Oncology, 58)
82% match

Breast Cancer: Progress in Biology, Clinical Management and Prevention: Proceedings of the International Association for Breast Cancer Research ... March 1989: 58 (Developments in Oncology, 58)

Springer

£108.01 06 Aug 2026
Nano Theragnostics in Breast Cancer: Advances, Challenges, and Future Prospects
82% match

Nano Theragnostics in Breast Cancer: Advances, Challenges, and Future Prospects

Springer

£147.11 03 Aug 2026
Breast Cancer (MD Anderson Solid Tumor Oncology Series)
82% match

Breast Cancer (MD Anderson Solid Tumor Oncology Series)

Springer

£78.01 13 Aug 2026